Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical benzoyl peroxide with or without clindamycin before total shoulder arthroplasty
ACTRN12618000261213Phase 4Recruiting
- Sponsor
- Orthopaedic Research Institute Queensland
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of benzoyl peroxide, clindamycin and Triclosan in shoulder osteoarthritis and Rotator cuff deficiency (RCD) (3 arms), sponsored by Orthopaedic Research Institute Queensland. Primary endpoint: Composite reduction in superficial colonization and deep tissue inoculation with Propionibacterium acnes. Started Jul 2018; status: recruiting.
02
Drugs
benzoyl peroxideclindamycinTriclosan
03
Conditions
shoulder osteoarthritisRotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ACTRN12618000261213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000261213.